Barrett’s oesophagus surveillance with optical biopsy using spectroscopy and enhanced endoscopic imaging to target high-risk lesions
Completed
- Conditions
- Barrett's oesophagus, dysplasia, aneuploidy or other molecular abnormalities and oesophageal adenocarcinomaCancer
- Registration Number
- ISRCTN58235785
- Lead Sponsor
- CL Biomedical Research Unit
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 2000
Inclusion Criteria
1. Patients will be recruited from those with Barrett’s oesophagus with or without other alterations (low-grade dysplasia [LGD] or high-grade dysplasia [HGD], any oesophageal or gastric cancer) undergoing endoscopy
2. Patients without Barrett’s oesophagus attending for a clinically indicated endoscopy may be recruited as controls
3. Patients must sign an informed consent form
Exclusion Criteria
1. Patients in whom endoscopy and biopsy is contraindicated
2. Patients who are unable to give informed consent
3. Pregnant women
4. People under the age of 21 years
5. People who are non-English speakers
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method